Prognostic implications of biopsy with tumor transection for patients with high-risk primary melanoma - 06/03/20
Doi : 10.1016/j.jaad.2020.01.067
Lena A. von Schuckmann, MBBS, MPH a, b, ⁎ 
, Kiarash Khosrotehrani, MD, PhD c, d, Maria Celia B. Hughes, MMedSci a, Jolieke C. van der Pols, PhD e, Maryrose Malt, BBus a, B. Mark Smithers, MBBS f, Adele C. Green, MBBS, PhD a, g
, Kiarash Khosrotehrani, MD, PhD c, d, Maria Celia B. Hughes, MMedSci a, Jolieke C. van der Pols, PhD e, Maryrose Malt, BBus a, B. Mark Smithers, MBBS f, Adele C. Green, MBBS, PhD a, g a Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia
b School of Public Health, The University of Queensland, Brisbane, Australia
c Experimental Dermatology Group, The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia
d Department of Dermatology, Princess Alexandra Hospital, Brisbane, Australia
e School of Exercise and Nutrition Sciences, Queensland University of Technology, Brisbane, Australia
f Queensland Melanoma Project, Princess Alexandra Hospital, University of Queensland, Brisbane, Australia
g Cancer Research UK Manchester and Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom
∗Correspondence to: Lena von Schuckmann, MBBS, MPH, QIMR Berghofer Institute of Medical Research, 300 Herston Rd, 4006 Herston, AustraliaQIMR Berghofer Institute of Medical Research300 Herston RdHerston4006Australia
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Friday 06 March 2020
Plan
| Funding sources: Supported by National Health and Medical Research Council Program grants 1073898 and 552429. Dr von Schuckmann is funded by National Health and Medical Research Council Postgraduate Scholarship 1133317, and Dr Khosrotehrani is funded by a National Health and Medical Research Council Career Development Fellowship. The funding body played no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. |
|
| IRB approval status: The study was approved by the Human Research Ethics Committees of the Metro South Health Service and the QIMR Berghofer Medical Research Institute. |
© 2020
Publié par Elsevier Masson SAS.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?